NCT04054271

Brief Summary

This study evaluates implant survival and marginal bone resorption in patients receiving implant treatment with respect to demographic data and AB0 (groups) blood types.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
963

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 13, 2019

Completed
Last Updated

August 13, 2019

Status Verified

August 1, 2019

Enrollment Period

1 year

First QC Date

August 6, 2019

Last Update Submit

August 8, 2019

Conditions

Implant Tissue Failure

Keywords

Blood types, Dental implant, Marginal Bone Resorption, Implant Survival

Outcome Measures

Primary Outcomes (2)

  • Marginal bone resorption measurements (mm) in dental implants.

    We evaluated marginal bone resorption in patients receiving implant treatment with respect to ABO blood types. These measurements will be measured by periapical radiographs. Periapical radiographs were taken with a parallel technique to measure the amount of mesial and distal bone resorption in the neck region of the implants.

    1 year

  • Implant survival rates according to demographic data

    We evaluated implant survival rates by age and sex on a yearly basis

    1 year

Eligibility Criteria

Age19 Years - 78 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This cross-sectional study was performed on patients who had undergone implant treatment and had prosthetic rehabilitation at the Faculty of Dentistry of the Van Yuzuncu Yil University between 2010 and 2017 and who had been followed up for at least one year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Serap Keskin Tunc

Van, 65100, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, DDA, Assistant professor

Study Record Dates

First Submitted

August 6, 2019

First Posted

August 13, 2019

Study Start

December 15, 2017

Primary Completion

December 15, 2018

Study Completion

December 15, 2018

Last Updated

August 13, 2019

Record last verified: 2019-08

Locations

TU(1)